The response of the skin microcirculation and of forearm skeletal muscle blood flow to infusion of a-human (99-126) atrial natriuretic factor (ANF) into the bra chial artery was investigated in 15 young (18-25 years) healthy volunteers in a double-blind, randomized, pla cebo-controlled study. The forearm blood flow (FBF) was measured with venous occlusion plethysmography, and the skin flux was measured by using laser Doppler fluxmetry (LDF). Dose-response curves were made us ing increasing dosages of ANF: 1, 10, and 100 ng/min/dl forearm volume. The FBF showed a significant, dosedependent increase during ANF infusion, averaging 107 + 22% during the highest ANF dosage, as compared with -5 ± 9% during placebo (p < 0.001). For the LDF, these
numbers were 34 ± 21 and -6 ± 10%, respectively (NS). In two subgroups of subjects, the effect of ANF on mi cro vascular reactivity was assessed by registering the vasoconstrictor response to cold exposure (n = 7) and the vasodilator response to arterial occlusion (n = 7). ANF did not change the microvascular response to these 1 stimuli. ANF induces a dose-dependent increase in skel etal muscle BF without a relevant response in the skin microcirculation. ANF does not play an important role in the regulation of skin perfusion. Key Words: 8-Human (99-126) atrial natriuretic factor-Skin microcirculation-Laser Doppler flux-Forearm blood flow-Plethysmog raphy .
The hormonal system of atrial natriuretic factor (ANF) comprises a family of polypeptides of which the 28-amino acid (99~126)-human ANF is the major circulating form (1) . ANF is considered to contrib ute essentially to the control of circulatory homeo stasis in physiological as well as in pathophysiolog ical conditions (2, 3) . ANF exerts important effects on the renin-angiotensin system and (p a ra s y m pathetic nervous system, in addition to having di rect vasodilator and renal actions (4, 5) . The marked vasodilator effects in vitro and in normal subjects have been described especially in large vessels (6, 7) . Some studies show controversial results of the vasodilator effect of ANF; e.g., data suggest that ANF may cause selective vasodilation of the kidney (8), contrary to data indicating no alteration in renal blood flow (9) . A N F has been demonstrated to increase dose dependently both skin perfusion and muscle blood flow (BF). In these particular studies, A N F was adm inistered intravenously in high dosages (10) , and intraarterially by infusion of supraphysiological (pharmacological) dosages (11) . Previously we demonstrated that the systemic A N F administration evokes a slight vasodilation in the skin microcirculation of healthy elderly humans (12) . We have now studied the effect of exogenous ANF on skin BF as indicated by laser Doppler flux (LDF: capillary and shunt BF in the skin) versus the effects of A N F on the skeletal muscle forearm BF (FBF) indicated by venous occlusion strain-gauge plethysmography. Because in vitro studies in rats have shown that A N F reverses a-adrenoceptormediated vasoconstriction (13) , we also investigate ed the effect of ANF on microvascular reactivity.
SUBJECTS AND METHOD
The study was approved by the local ethics committee. A group of healthy young volunteers (n = 15), recruited from the general population was submitted to clinical ex amination before admission to the study. Physical exam ination and laboratory investigation showed no abnormal ities. None of the subjects used any drugs (oral contra ceptives included) or abused alcohol. The subjects were instructed to abstain from smoking and not to drink any coffee or tea for 24 h preceding the experiment.
Study design
The study was performed during a 4-h immobilization period in a climatized room (temperature ± SD: 22.6° ± 0.2°C; n = 15). The subjects were allowed to eat a light meal, but not within 2 h before the test. The tests were performed after an equilibration period of at least 45 min with the subjects in the supine position.
The left brachial artery was cannulated with a 20-gauge Angiocath cannula (Deseret Medical, Becton Dickinson, Sandy, U.S.A. UT, U.S.A.) for drug infusion (automatic syringe infusion pump, type STC-521, Terumo, Tokyo, Japan) as well as for blood pressure (BP) monitoring (Hewlett Packard monitor, type 78353B, Hewlett Packard GmbH, Böblingen, Germany). Because the dosages of all drugs were calculated per deciliter of forearm volume, this volume was measured in all participants by water displacement. The subjects remained supine throughout the 4-h study period.
During the study, systolic and diastolic BP (SBP, DBP) and mean arterial pressure (MAP) were recorded intra arterially. Heart rate (HR) was monitored continuously by ECG registration. FBF was measured by venous oc clusion plethysmography with mercury-in-rubber strain gauges (Loosco BVP 96 Hoekloos, Amsterdam, Hol land). A cuff was placed around the left arm, proximal to the strain gauge. Venous occlusion was attained by infla tion of the cuff to 40 mmHg. Each FBF recording period took 4 min, during which time nine recordings were ob tained. During the measurements, the left arm was main tained at heart level (14) . Digital skin blood flux was re corded continuously with laser Doppler fluxmetry (Periflux Pf Id, Perimed, Sweden). The laser light penetrates to a maximum depth of 1.5 mm depending on skin com position. The Doppler flux reflects skin microcirculation, including nutritional capillaries and arteriovenous shunt flow (15, 16) , The flux was expressed in perfusion units (PU). To the center of the left distal palmar tip of the third finger, a 90° angular probe was attached by a double-sided adhesive ring. Before each experiment, an electrical cal ibration procedure was performed according to the man ual; i.e., the probe was placed in a calibration clip on zero surface, and the recorder pen was moved to zero on the recorder. To correct flux registration for spontaneous vasomotion, biological zeroing was performed during total occlusion of the finger circulation for 5 min. Skin temper ature was measured in degrees Centigrade (Thermocou ple, Ellab Instruments, Denmark) with the probe attached to the palmar side of the middle phalanx on the third finger. All parameters were measured during the several infusions of the study.
ANF or placebo was infused into the brachial artery in random order. Three increasing dose steps were admin istered: 1, 10, and 100 |ULg/min/dl forearm tissue for 10 min per dose. To evaluate the effect of ANF/placebo on the microvascular reactivity, the highest dose of ANF or pla cebo infusion was continued to perform a finger cooling test in a subgroup of 7 subjects or a post occlusive reac tive hyperaemia test in 7 other subjects. In the finger cooling test, finger skin temperature and LDF were mea sured during a 25-min period, beginning with a 5-min cooling procedure in water of 15°C, as described previ ously (17). The postocclusive reactive hyperemia test was performed by inflating a finger cuff to 230 mm Hg for 5 min (18) . After the cuff was released, the LDF was reg istered for 10 min. After a new equilibration period of 45 min, the same procedure was repeated, but with infusion of the alternate agent, placebo or ANF.
Drugs
a-Human (99-126) ANF was purchased from Bissendorf Peptide GmbH, Wedemark, Germany. Immediately before use, ANF was diluted in a 48-ml Haemaccel (Hoechst) solution. Haemaccel is a plasma-expanding solu tion and was used for placebo infusion, as well as for dissolving ANF, Results of pilot studies showed that dis solving iodinated ANF in Haemaccel solution resulted in a 20% loss of radioactivity to the infusion system as com pared with a 50% loss when ANF was dissolved in 0.9% in saline solution, as we reported previously (12) .
Data
All results are mean ± SEM unless indicated other wise. LDF was averaged over the last 5 min of each ANF infusion dosage. FBF was calculated as the mean of all registration during the last 4 min of each dose.
Statistical analysis
To determine the effects of ANF infusion within each group of subjects, we compared the absolute as well as percentage ANF-induced changes with corresponding placebo observations for each infusion rate by analysis of variance (ANOVA) with repeated measures. In case of a significant ANF effect, Fisher PLSD tests (protected least significant difference) were used as post hoc tests to analyze the differences between baseline and the several ANF dosages and also for the analysis of the finger cool ing tests and the postocclusive reactive hyperemia tests. Differences were considered statistically significant at p < 0.05. ± 0.4 ml/min/dl during the highest ANF dose (p < 0.001). Table 1 
RESULTS

In all, 9 males and 6 females participated in the study. Their mean (±SD) age, body mass index, SDB/DBP, and HR was 25 ± 4 years, 22 ± 2 kg/m2, 125 ± 6/73 ± 6 mm Hg, and 74 ± 12 beats/min, respectively. The serum creatinine concentrations averaged 72 ± 9 \lM>
Effects of ANF on baseline parameters (n = 15) \ Figure 1 shows the absolute changes from base line induced by graded infusion of ANF or placebo for the FBF as well as for the LDF. The baseline FBF was 2.1 ± 0.3 ml/min/dl in both the placebo and the ANF test. Corrected for the changes in
summarizes the percentage changes from baseline after ANF and after placebo and also shows a dose-dependent increase in FBF after ANF as compared with placebo.
The baseline LDF averaged 10.7 ± 2.6 PU in the placebo test and 8.5 ± 2.2 PU in the ANF test. This parameter increased slightly, though significantly, after the three ANF infusions (placebo-corrected changes: 1.4 ± 1.3, 3.3 ± 2.2, and 4.2 ± 2 .0 PU, p < 0.05). As shown in Table 1 , the ANF-induced percentage changes from baseline were slight and not significantly different from those induced by placebo.
Effect of ANF on mlcrovascular reactivity
In the placebo series, cold exposure to the fingers did not change the FBF (1.7 ± 0.1 at baseline and  1.6 ± 0.1 immediately after cold exposure, n = 7) . However, during the procedure, LDF decreased from 9.9 ± 2,3 to 6.1 ± 2.0 PU. In the recovery phase, the LDF gradually increased to 7,0 ±3.7 PU after 25 min. For the skin temperature, these values averaged 29.0° ± 0.5°C at baseline, 21.2° ± 0.5°C immediately after cold exposure, and 23.1° ± 1.6°C after 25 min of recovery. Although the highest dose of ANF increased the baseline values of FBF and LDF, the course of these parameters after cold ex posure was not changed by ANF as compared with placebo.
In the placebo series, the peak response of the LDF after occlusion of the finger was 21.1 ±2.9 PU and reached 48. 
DISCUSSION
We demonstrated that infusion of ANF into the brachial artery induced a significant dose-depen dent increase in FBF but only a slight increase in skin flux in healthy subjects. Plethysmographic FBF measurement includes both skeletal muscle BF and skin BF. The increase in FBF was more pronounced than the changes in skin flux. There fore, the changes in the plethysmography values in this study must be attributed mainly to increases in skeletal muscle BF. The magnitude of the effects on skin microcirculation was remarkably small and ap peared to occur only at the highest dose o f ANF. We observed large differences between control val ues of LDF before ANF and placebo infusion. Be cause the sequence of testing was randomized, a time effect cannot explain this difference in baseline 
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level. Large differences in LD F were observed and described previously. Despite this variability, LDF is considered useful in measuring skin microcirculatory reactivity during interventions (17, 19) . Previ ous studies in our departm ent have shown that the regional A N F concentrations reached at the highest dose are much higher than in (patho)physiological conditions (20) . By dividing the A N F infusion rate by the forearm plasma flow (FBF x [l-hematocrit])5 the regional plasma A N F concentrations during the lowest dose of 1 ng/min/dl can be estimated as ~1 ng/ml, w hereas physiological concentrations are generally <0.1 ng/ml. Therefore, our results indi cate that only supraphysiological levels of ANF in duce a slight vasodilator response in the microcir culation.
Contradictory reports on the microcirculatory ef ficacy of A N F have been published previously (10, 11) . In a previous study, using the intravenous route of A N F adm inistration, we reported that A N F was not a potent vasodilator in the skin mi crocirculation. H ow ever, systemic administration of A N F is complicated by cardiovascular reflex ac tivity compensating for induced effects. Therefore, in the present study, we used the regional route of A N F administration to rule out the influence of com pensatory m echanism s. Our current results suggest that A N F plays only a minor direct vasodi lator role in normal skin microcirculation, in con trast to a more pronounced vasodilator effect on skeletal muscle BF.
We further investigated possible modulatory ef fects of A N F on the a-adrenoceptor-m ediated mi crocirculatory constrictor response to finger cool ing. The postsynaptic a-adrenoceptor-m ediated vasoconstrictor response to cold exposure in hu man skin microcirculation is believed to be predom inantly mediated by the a 2-subtype (21) . In vivo studies with selective a r and a 2-agonists have sup ported the concept of heterogeneity of postjunc tional a-adrenoceptors in human vasculature. Faber and colleagues demonstrated that A N F was highly potent in selectively reversing a r adrenoceptormediated constriction (13) , but in their study a 2adrenoceptor-m ediated constriction was ANF in sensitive, which may explain the absence of an ef fect of A N F on cold-induced vasoconstriction in our study. Our experiments with postocclusive re active hyperem ia indicate that A N F apparently does not modulate microvascular vasodilator func tion.
A N F induces a direct dose-dependent vasodilator effect on the skeletal muscle vascular bed. In sup raphysiological concentrations, A N F can also dilate the skin microcirculation, but does not appear to change microvascular reactivity.
